In various preclinical models, BT2 is protective from glucose intolerance, insulin insensitivity, triglyceride accumulation, and hepatic inflammation similarly to DNP derivatives or Bam15 (22, 24, 26, 29, 46, 63, 64). This evidence concerns the gene INS and Glucose intolerance.